DexCom(US:DXCM) Businesswire·2026-01-12 12:30Core Insights - Dexcom reported preliminary, unaudited results for the fourth quarter and fiscal year 2025, indicating strong performance and growth in the continuous glucose monitoring market [1] Financial Performance - For the fourth quarter of 2025, Dexcom's revenue is projected to be approximately $600 million, representing a year-over-year increase of 20% [1] - The total revenue for fiscal year 2025 is expected to reach around $2.3 billion, marking a 25% growth compared to fiscal year 2024 [1] 2026 Outlook - The company provided an initial outlook for 2026, forecasting revenue growth to approximately $2.8 billion, which would indicate a 22% increase from 2025 [1] - Dexcom anticipates continued expansion in its customer base and product offerings, contributing to sustained revenue growth in the upcoming year [1]